FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2222467484> ?p ?o ?g. }

• W2222467484 endingPage "9149" @default.
• W2222467484 startingPage "9149" @default.
• W2222467484 abstract "9149 Background: Sunitinib (SUN) and sorafenib (SOR) are oral tyrosine kinase inhibitors approved for renal cell carcinoma and gastrointestinal stromal tumors (SUN) and hepatocellular carcinoma (SOR). Sporadic reports of thyroid dysfunction and hypertension (HTN) have been made with these agents. Determination of the true side effect incidence will allow for more efficient monitoring and treatment recommendations. Methods: An observational cohort study was performed using de-identified pharmacy claims data from 2006 to 2009 to evaluate patients (pts) who were prescribed SUN, SOR or capecitabine (CAP). The primary outcome was time to first prescription for thyroid replacement (TR) or HTN treatment. CAP was used as a comparison group for drug-induced hypothyroidism or HTN. Pts were included if they had at least 2 consecutive prescriptions or 45 days of consecutive therapy. Exclusion criteria included presence of concurrent prescriptions for other oral cancer therapies or active prescriptions for TR or HTN therapy. Hazard ratios (HR) with 95% confidence intervals (CI) were estimated by cox proportional hazards models adjusted for age, sex and chronic disease score. Results: A total of 20,061 pts were eligible for evaluation of TR therapy, 1,965 receiving SUN, 1,790 SOR and 16,306 CAP. TR therapy was initiated in 11.6% of those receiving SUN (HR 16.77, CI 13.54, 20.76), 2.6% SOR (HR 3.47, CI 2.46, 4.98) and 1% CAP The median time for needing TR therapy was 4 months. A total of 14,468 pts were eligible for evaluation of HTN therapy, 1,207 SUN, 1,102 SOR, and 12,159 CAP. HTN therapy was initiated in 21% of those receiving SUN (HR 4.91 CI 4.19, 5.74), 14% SOR (HR 3.25, CI 2.69, 3.91), and 5% capecitabine. The median time for needing HTN therapy was 2 months. Conclusions: Pts receiving SUN and SOR have a similar, but elevated, risk of clinically relevant HTN. Clinically relevant hypothyroidism is more than 4 times more common with SUN than SOR. Clinically relevant hypothyroidism usually occurs between 1 and 7 months after the initiation of SUN or SOR therapy. This data provides robust measures of the incidence of these clinically actionable adverse events and implies mechanistic distinctions between the two agents. No significant financial relationships to disclose." @default.
• W2222467484 created "2016-06-24" @default.
• W2222467484 creator A5005968451 @default.
• W2222467484 creator A5016751056 @default.
• W2222467484 creator A5025588314 @default.
• W2222467484 creator A5045371171 @default.
• W2222467484 creator A5049264511 @default.
• W2222467484 creator A5050465459 @default.
• W2222467484 creator A5065552858 @default.
• W2222467484 creator A5086561093 @default.
• W2222467484 date "2010-05-20" @default.
• W2222467484 modified "2023-09-23" @default.
• W2222467484 title "Pharmacoepidemiology of clinically relevant hypothyroidism and hypertension from sunitinib and sorafenib." @default.
• W2222467484 doi "https://doi.org/10.1200/jco.2010.28.15_suppl.9149" @default.
• W2222467484 hasPublicationYear "2010" @default.
• W2222467484 type Work @default.
• W2222467484 sameAs 2222467484 @default.
• W2222467484 citedByCount "1" @default.
• W2222467484 crossrefType "journal-article" @default.
• W2222467484 hasAuthorship W2222467484A5005968451 @default.
• W2222467484 hasAuthorship W2222467484A5016751056 @default.
• W2222467484 hasAuthorship W2222467484A5025588314 @default.
• W2222467484 hasAuthorship W2222467484A5045371171 @default.
• W2222467484 hasAuthorship W2222467484A5049264511 @default.
• W2222467484 hasAuthorship W2222467484A5050465459 @default.
• W2222467484 hasAuthorship W2222467484A5065552858 @default.
• W2222467484 hasAuthorship W2222467484A5086561093 @default.
• W2222467484 hasConcept C120665830 @default.
• W2222467484 hasConcept C121332964 @default.
• W2222467484 hasConcept C126322002 @default.
• W2222467484 hasConcept C207103383 @default.
• W2222467484 hasConcept C2426938 @default.
• W2222467484 hasConcept C2777472916 @default.
• W2222467484 hasConcept C2778019345 @default.
• W2222467484 hasConcept C2778695046 @default.
• W2222467484 hasConcept C2778715236 @default.
• W2222467484 hasConcept C2779490328 @default.
• W2222467484 hasConcept C44249647 @default.
• W2222467484 hasConcept C61511704 @default.
• W2222467484 hasConcept C71924100 @default.
• W2222467484 hasConcept C72563966 @default.
• W2222467484 hasConcept C90924648 @default.
• W2222467484 hasConcept C98274493 @default.
• W2222467484 hasConceptScore W2222467484C120665830 @default.
• W2222467484 hasConceptScore W2222467484C121332964 @default.
• W2222467484 hasConceptScore W2222467484C126322002 @default.
• W2222467484 hasConceptScore W2222467484C207103383 @default.
• W2222467484 hasConceptScore W2222467484C2426938 @default.
• W2222467484 hasConceptScore W2222467484C2777472916 @default.
• W2222467484 hasConceptScore W2222467484C2778019345 @default.
• W2222467484 hasConceptScore W2222467484C2778695046 @default.
• W2222467484 hasConceptScore W2222467484C2778715236 @default.
• W2222467484 hasConceptScore W2222467484C2779490328 @default.
• W2222467484 hasConceptScore W2222467484C44249647 @default.
• W2222467484 hasConceptScore W2222467484C61511704 @default.
• W2222467484 hasConceptScore W2222467484C71924100 @default.
• W2222467484 hasConceptScore W2222467484C72563966 @default.
• W2222467484 hasConceptScore W2222467484C90924648 @default.
• W2222467484 hasConceptScore W2222467484C98274493 @default.
• W2222467484 hasIssue "15_suppl" @default.
• W2222467484 hasLocation W22224674841 @default.
• W2222467484 hasOpenAccess W2222467484 @default.
• W2222467484 hasPrimaryLocation W22224674841 @default.
• W2222467484 hasRelatedWork W2018531014 @default.
• W2222467484 hasRelatedWork W2150001502 @default.
• W2222467484 hasRelatedWork W2168054139 @default.
• W2222467484 hasRelatedWork W2182272419 @default.
• W2222467484 hasRelatedWork W2217018444 @default.
• W2222467484 hasRelatedWork W2511626760 @default.
• W2222467484 hasRelatedWork W2909882862 @default.
• W2222467484 hasRelatedWork W2971476881 @default.
• W2222467484 hasRelatedWork W2996164021 @default.
• W2222467484 hasRelatedWork W3013787684 @default.
• W2222467484 hasVolume "28" @default.
• W2222467484 isParatext "false" @default.
• W2222467484 isRetracted "false" @default.
• W2222467484 magId "2222467484" @default.
• W2222467484 workType "article" @default.